A Dose Finding Study to Assess the Effect of LIK066 Compared to Placebo or Empagliflozin in Patients With Type 2 Diabetes Mellitus and Heart Failure
Clinical trial NCT03152552 · TERMINATED
Trial details
- NCT number
- NCT03152552
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-25
- Primary completion
- 2018-06-06
- Enrollment
- 125
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.